Jason Truman

Jason Truman is a Senior Managing Director at Leerink Partners focused on Biopharma Mergers & Acquisitions.

Prior to joining the Firm in 2024, Jason most recently was Senior Managing Director in the Biopharma Investment Banking Practice of Guggenheim Securities. Jason brings over 20 years of investment banking experience, where he advised a wide variety of domestic and international biopharma clients in connection with mergers and acquisitions, divestitures, spin-offs/split-offs, takeover defense, proxy contests and capital raising. Specifically, Jason has advised on strategic transactions that have involved leaders in the space including such companies as Gilead, Merck, Pfizer, Alexion, Arena Pharmaceuticals, NGM Bio, and Revolution Medicines. Prior to joining Guggenheim Securities, Jason specialized in mergers and acquisitions in the biopharma space working at firms including Credit Suisse and Morgan Stanley. 

He earned his MBA from the Darden School of Business at the University of Virginia and a BBA from the Ross School of Business at the University of Michigan.